Valmark Advisers, Inc. Gilead Sciences, Inc. Transaction History

Valmark Advisers, Inc.

$6.34 Billion
Q3 2024

A detailed history of Valmark Advisers, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Valmark Advisers, Inc. holds 3,555 shares of GILD stock, worth $314,262. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,555

Previous 4,173 14.81%

Holding current value

$314,262

Previous $286,000 3.85%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$66.59 - $83.99 $41,152 - $51,905	-618 Reduced 14.81%	3,555 $297,000
Q2 2024 Jul 31, 2024	BUY	$63.15 - $72.88 $24,249 - $27,985	384 Added 10.13%	4,173 $286,000
Q1 2024 May 03, 2024	SELL	$71.58 - $87.29 $31,996 - $39,018	-447 Reduced 10.55%	3,789 $277,000
Q4 2023 Feb 02, 2024	SELL	$73.27 - $83.09 $53,194 - $60,323	-726 Reduced 14.63%	4,236 $343,000
Q3 2023 Nov 07, 2023	SELL	$73.94 - $80.67 $5,841 - $6,372	-79 Reduced 1.57%	4,962 $371,000
Q2 2023 Aug 02, 2023	BUY	$76.01 - $86.7 $6,232 - $7,109	82 Added 1.65%	5,041 $388,000
Q1 2023 May 01, 2023	BUY	$77.31 - $88.08 $7,576 - $8,631	98 Added 2.02%	4,959 $411,000
Q4 2022 Feb 06, 2023	BUY	$62.32 - $89.47 $38,513 - $55,292	618 Added 14.57%	4,861 $417,000
Q3 2022 Nov 02, 2022	SELL	$59.54 - $68.01 $1,488 - $1,700	-25 Reduced 0.59%	4,243 $262,000
Q2 2022 Aug 01, 2022	SELL	$57.72 - $65.01 $981 - $1,105	-17 Reduced 0.4%	4,268 $264,000
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $18,302 - $22,935	-316 Reduced 6.87%	4,285 $255,000
Q4 2021 Feb 02, 2022	SELL	$64.88 - $73.64 $45,026 - $51,106	-694 Reduced 13.11%	4,601 $334,000
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $11,574 - $12,488	-171 Reduced 3.13%	5,295 $370,000
Q2 2021 Aug 06, 2021	BUY	$63.47 - $69.35 $571 - $624	9 Added 0.16%	5,466 $376,000
Q1 2021 May 04, 2021	BUY	$60.0 - $68.46 $81,960 - $93,516	1,366 Added 33.39%	5,457 $353,000
Q4 2020 Feb 03, 2021	BUY	$56.65 - $64.55 $231,755 - $264,074	4,091 New	4,091 $238,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valmark Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Valmark Advisers, Inc. with notifications on news.

Account

Valmark Advisers, Inc. Gilead Sciences, Inc. Transaction History